Recro Pharma Inc. | Ownership
Companies that own Recro Pharma Inc.
Broadfin Capital LLC
2,048,025
9.89%
-188,000
1.8%
06/30/2018
BlackRock Fund Advisors
1,054,471
5.09%
274,875
0%
06/30/2018
Alyeska Investment Group LP
900,982
4.34%
50,412
0.06%
06/30/2018
Newtyn Management LLC
887,700
4.29%
887,700
1.01%
06/30/2018
The Vanguard Group, Inc.
715,919
3.46%
68,811
0%
06/30/2018
Lyon Street Capital LLC
488,596
2.36%
-538,675
0.98%
06/30/2018
Engine Capital Management LLC
391,307
1.89%
322,937
1.78%
06/30/2018
Renaissance Technologies LLC
381,300
1.84%
18,700
0%
06/30/2018
Manulife Asset Management (US) LLC
293,688
1.42%
64,279
0%
06/30/2018
Sanders Morris Harris LLC (Investment Management)
277,085
1.34%
277,085
0.79%
06/30/2018
| Address |
490 Lapp Road
Malvern Pennsylvania 19355
United States
|
|
Employees
|
- |
| Website |
http://www.recropharma.com |
| Updated |
07/08/2019 |
| Recro Pharma, Inc. is a pharmaceutical company, which engages in the research and development of non-opioid therapeutics for the treatment of acute post operative pain. It operates through the Acute Care, and Contract Development and Manufacturing (CDMO) business segment. The Acute Care segment focuses on developing innovative products for hospital and related settings. |
